Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSIF.L Regulatory News (SSIF)

  • There is currently no data for SSIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

25 Sep 2015 16:49

RNS Number : 2932A
GLI Alternative Finance PLC
25 September 2015
 



 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

GLI Alternative Finance Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Morgan Stanley

(Institutional Securities Group and Global Wealth Management)

4. Full name of shareholder(s)  (if different from 3.):iv

Morgan Stanley & Co. International plc

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

23/09/2015

6. Date on which issuer notified:

25/09/2015

7. Threshold(s) that is/are crossed orreached: vi, vii

3%,4%,5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00BYMK5S87

 

Below 3%

 

 

Below 3%

 

3,000,000

3,000,000

 

 

5.69%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,000,000

5.69%

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA is a direct holder of  3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley Investments (UK)

 

Morgan Stanley Investments (UK), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley UK Group

 

Morgan Stanley UK Group, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley Group (Europe)

 

Morgan Stanley Group (Europe), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley International Limited

 

Morgan Stanley International Limited, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley International Holdings Inc.

 

Morgan Stanley International Holdings Inc, c/o The Corporation Trust Company, Corporation Trust Centre, 1209 Orange Street, Wilmington, Delaware DE19801, USA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley.

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

 

 

14. Contact name:

Craig Horsley

15. Contact telephone number:

0141 245 7736

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVSVRVNAKUAR
Date   Source Headline
14th Mar 20179:00 amRNSHalf-year Report
10th Mar 20172:30 pmRNSHolding(s) in Company
10th Mar 20172:30 pmRNSHolding(s) in Company
9th Mar 20179:30 amRNSNet Asset Value(s)
8th Mar 20177:00 amRNSUpdate re. Proposals for the Company's Future
21st Feb 20177:00 amRNSProposals for the Company's Future
15th Feb 20173:00 pmRNSDividend Declaration
7th Feb 20177:00 amRNSMonthly Fact Sheet
6th Feb 20172:30 pmRNSNet Asset Value(s)
12th Jan 201711:00 amRNSDividend Declaration
11th Jan 20175:00 pmRNSMonthly Fact Sheet
10th Jan 20171:30 pmRNSNet Asset Value(s)
14th Dec 20164:00 pmRNSMonthly Fact Sheet - Replacement
14th Dec 20169:00 amRNSMonthly Fact Sheet - Replacement
13th Dec 20162:00 pmRNSMonthly Fact Sheet
12th Dec 20163:14 pmRNSDividend Declaration - Replacement
12th Dec 20169:00 amRNSDividend Declaration
9th Dec 20162:34 pmRNSResult of AGM
9th Dec 201610:00 amRNSNet Asset Value(s)
21st Nov 201610:00 amRNSDividend Declaration
11th Nov 20169:30 amRNSMonthly Fact Sheet
8th Nov 201610:15 amRNSNet Asset Value(s)
7th Nov 201611:32 amRNSFund Manager Share Purchase
25th Oct 20167:00 amRNSDividend Declaration
17th Oct 20167:00 amRNSAnnual Financial Report
12th Oct 201610:15 amRNSMonthly Fact Sheet
10th Oct 20162:05 pmRNSNet Asset Value(s)
3rd Oct 20167:00 amRNSPortfolio Update
21st Sep 201610:00 amRNSDividend Declaration
14th Sep 20161:45 pmRNSMonthly Fact Sheet
9th Sep 20163:33 pmRNSNet Asset Value(s)
6th Sep 20169:48 amRNSUpdate research from QuotedData
1st Sep 20168:00 amRNSChange of Name
1st Sep 20167:00 amRNSChange of Adviser
23rd Aug 20167:00 amRNSDividend Declaration
16th Aug 20169:45 amRNSMonthly Fact Sheet
9th Aug 20167:00 amRNSNet Asset Value(s)
3rd Aug 201611:50 amRNSResult of General Meeting
22nd Jul 20161:00 pmRNSChange of Name
19th Jul 20163:24 pmRNSDirector Resignation
14th Jul 201610:00 amRNSDividend Declaration
13th Jul 20162:30 pmRNSMonthly Fact Sheet
8th Jul 20169:30 amRNSNet Asset Value(s)
7th Jul 20167:00 amRNSNotice of GM
28th Jun 201611:00 amRNSDividend Declaration
21st Jun 20168:06 amRNSDirectorate Change
16th Jun 20168:26 amRNSMonthly Fact Sheet
14th Jun 201610:55 amRNSNet Asset Value(s)
25th May 20167:00 amRNSDividend Declaration
16th May 20164:51 pmRNSMonthly Fact Sheet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.